LakeShore Biopharma Co., Ltd. (LSBCF) › Operating Cash FlowLakeShore Biopharma Co., Ltd. (LSBCF) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2021: -246.61M CNY2022: -173.55M CNY2023: -182.47M CNY2024: -295.23M CNY2025: -120.98M CNY-120.98M CNY2021Operating Cash Flow (CNY)2025Fiscal YearOperating Cash FlowChange YoY2025-120.98M CNY+59.0%2024-295.23M CNY-61.8%2023-182.47M CNY-5.1%2022-173.55M CNY+29.6%2021-246.61M CNY—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share